Navigation Links
Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
Date:5/8/2008

ts & Figures 2007; Publication of the American Cancer Society, Atlanta, Georgia. View this document on the following link: http://www.cancer.org/docroot/STT/content/STT_1x_Global_Cancer_Facts_and_Fi gur es_2007.asp (Due to length of URL, Please copy and paste link into browser. Remove the space if one exists).


'/>"/>
SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
2. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
3. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
4. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
5. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
11. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/8/2008)... Nation,s Largest Renal Research Network Completes...Active Trials in Late Stage Development, EL SEGUN...Research(R),(DCR), a Phase I-IV clinical trial res...ed drug and device research and development for FD...al trials in 2007 and has another 34,active trials...
(Date:5/8/2008)... MIAMI, May 8 /- Globus Medical, Inc...acturer in the world and a recognized,leader in mo...completion of,enrollment in its SECURE(R)-C Cervic...ce is designed to mimic the normal motion of the s...on as an alternative to fusion in,the treatment of...
(Date:5/8/2008)...VYVANSE demonstrated significant improvement in AD...ire-FirstCall/ -- Shire plc (LSE: SHP,Nasdaq: SHP...y, today,presented the results of a phase III pivo...t improvements in Attention Deficit Hyperactivity,...ety and efficacy,endpoints., "Adults with ADHD of...
(Date:5/8/2008)... TAMPA, Fla., May 8 /- Alp...aceutical company, today announced results from,cl...phine sulfate,extended-release with sequestered na...ically relevant features addressing abuse liabilit...e. The Phase I and II,studies, presented at the 27...
Breaking Medicine Technology:DaVita Clinical Research Completes Record Number of Renal Trials in 2007 2Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Getting forgetful 3F Then blueberries may hold the key 16483 1Getting forgetful 3F Then blueberries may hold the key 16483 2Deafness Research Foundation 50th Anniversary Celebration 16478 1Deafness Research Foundation 50th Anniversary Celebration 16478 2The HealthCentral Network Adds New Hope Medias ADDitudemag com to its Premier Network of High Quality Sites 16473 1The HealthCentral Network Adds New Hope Medias ADDitudemag com to its Premier Network of High Quality Sites 16473 2The HealthCentral Network Adds New Hope Medias ADDitudemag com to its Premier Network of High Quality Sites 16473 3Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients 1736 1Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients 1736 2Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients 1736 3
...ata Presented at ASCO -, CHICAGO, June 04, 2007 /P...ay that Soliris(TM) (eculizumab), a new treatment ...loped by Alexion,Pharmaceuticals, Inc. , is effect...ory of aplastic anemia (AA) or myelodysplastic,syn...ood cell,destruction (hemolysis), decreased or eli...
...-Jun 4, 2007 - Genentech, Inc. (NYSE:DNA),today an...wo Phase,III clinical trials studying Herceptin(R)...positive breast cancer. Data presented,at the 43rd...l,Oncology (ASCO) showed that, with median follow-...n to standard adjuvant therapy,significantly impro...
Other Medicine Technology:Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 2Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 3Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 5Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 6
(Date:5/11/2008)...e House Correspondent Richard,Wolffe examines Bara...ial,candidate,s leadership and management style an... war with John McCain and the Republicans. Obama,s...ig issues because there,are stark contrasts betwee...e also ready for attacks from another "527" group,...
(Date:5/11/2008)...e/ -- Today, a commercial,airplane carrying the fi...,touched down in Yangon, Myanmar, to assist surviv... includes an initial supply of 8,000,insecticide-t... malaria., "This is a very critical time for surv...ble to diseases, like malaria," said David Meltzer...
(Date:5/11/2008)... and, sometimes, surgery, , , SUNDAY,...ally curved and flexible so that you can bend, twi...natural curve of the spine doesn,t develop properl... This condition is known as scoliosis and it affec...ional Scoliosis Foundation. While it isn,t a dange...
(Date:5/10/2008)...vastating vision injuries, group says , ,...in the United States, about 40,000 people suffer s...emy of Ophthalmology (AAO), which recommends that ... protection properly fitted by an eye-care profess...ls offer the highest level of impact protection. T...
Breaking Medicine News(10 mins):Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 3Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 4Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 5Health News:Relief Supplies from American Red Cross Arrive in Myanmar 2Health News:Scoliosis: An Unnatural Curve 2Health News:Scoliosis: An Unnatural Curve 3Health News:Protective Eyewear Key to Sports Safety 2
...w imaging technology is expected to help physician...ng is an ultrasound technique recently cleared by ...ess of tissue, relative to surrounding areas. This...for biopsies. In fact, the American Cancer Society...
...southeastern Michigan have been depleted due to em...Red Cross is issuing a call to action to everyone ...e Southeastern Michigan Blood Service Region of th... Type O-negative -- the universal blood type -- on...
...y today announced that it has received approval fr...market over-the-counter coated nicotine polacrilex...it). The product will be marketed under store br...xoSmithKline's Nicorette(R) Fruit Chill(TM) coated...
...e tend to lose muscle mass and grow frail? One imp... reduced ability of the elderly to respond to the ... Insulin is best known for its link to diabetes a...e lack of insulin or systemic resistance to the ho...
Other Medicine News:Health News:Perrigo Receives FDA Approval to Market Coated Fruit Nicotine Gum 2Health News:Aerobic Exercise Helps Maintain Muscle in Elderly: Research 2
Used for temporary internal drainage from the ureteropelvic junction to the bladder. Endpoint stents feature closed ends and are designed for open surgical and optional one-pass endoscopic placement.
Used for temporary internal drainage from the ureteropelvic junction to the bladder. The filiform stent assembly provides one pass placement. Supplied sterile in peel-open packages. Intended for one-
...lla-zoster virus infection is the prevention of co...th active infection. Antibodies to varicella-zost...ralizing antibody, or fluorescent antibody techniq...ntigen (FAMA) assay. The FAMA assay has proven to...
The Needle Loading Platform / Shield is designed to provide superior operator shielding during the loading of prostate implant needles with iodine or palladium seeds. It is constructed of 3/8" alumin
Medicine Products: